Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Miles

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
The Journal of Organic Chemistry|July 12, 1974
Pyrazolopyrimidine nucleosides. V. Methylation of the C-nucleoside antibiotic formycin and structural elucidation of products by magnetic circular dichroism spectroscopyL B Townsend, R A Long, J P McGraw, et al.
Histopathology|May 10, 2006
Different patterns of inflammation and prognosis in invasive carcinoma of the breastA H S Lee, C E Gillett, K Ryder, et al.
Lancet (London, England)|June 30, 1990
Reconstitution of interleukin 2 with albumin for infusionD W Miles, C R Bird, M Wadhwa, et al.
International Journal of Cancer|March 15, 1994
Expression of tumour necrosis factor (TNF alpha) and its receptors in benign and malignant breast tissueD W Miles, L C Happerfield, M S Naylor, et al.
British Journal of Cancer|December 1, 1994
Expression of sialyl-Tn predicts the effect of adjuvant chemotherapy in node-positive breast cancerD W Miles, L C Happerfield, P Smith, et al.
British Journal of Cancer|October 1, 1996
A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancerD W Miles, K E Towlson, R Graham, et al.
British Journal of Cancer|May 1, 1993
Activity of type IV collagenases in benign and malignant breast diseaseB Davies, D W Miles, L C Happerfield, et al.
The Journal of Pathology|March 29, 2001
Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breastC E Gillett, D W Miles, K Ryder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancerM Dowsett, C Pfister, S R Johnston, et al.
British Journal of Cancer|July 2, 1998
Family history and survival in premenopausal breast cancerS N Mohammed, P Smith, S V Hodgson, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
The Journal of Organic Chemistry|July 12, 1974
Pyrazolopyrimidine nucleosides. V. Methylation of the C-nucleoside antibiotic formycin and structural elucidation of products by magnetic circular dichroism spectroscopyL B Townsend, R A Long, J P McGraw, et al.
Histopathology|May 10, 2006
Different patterns of inflammation and prognosis in invasive carcinoma of the breastA H S Lee, C E Gillett, K Ryder, et al.
Lancet (London, England)|June 30, 1990
Reconstitution of interleukin 2 with albumin for infusionD W Miles, C R Bird, M Wadhwa, et al.
International Journal of Cancer|March 15, 1994
Expression of tumour necrosis factor (TNF alpha) and its receptors in benign and malignant breast tissueD W Miles, L C Happerfield, M S Naylor, et al.
British Journal of Cancer|December 1, 1994
Expression of sialyl-Tn predicts the effect of adjuvant chemotherapy in node-positive breast cancerD W Miles, L C Happerfield, P Smith, et al.
British Journal of Cancer|October 1, 1996
A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancerD W Miles, K E Towlson, R Graham, et al.
British Journal of Cancer|May 1, 1993
Activity of type IV collagenases in benign and malignant breast diseaseB Davies, D W Miles, L C Happerfield, et al.
The Journal of Pathology|March 29, 2001
Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breastC E Gillett, D W Miles, K Ryder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancerM Dowsett, C Pfister, S R Johnston, et al.
British Journal of Cancer|July 2, 1998
Family history and survival in premenopausal breast cancerS N Mohammed, P Smith, S V Hodgson, et al.
Pageof 8